Homebiotech

biotech

DEADLINE ALERT for EIGR, TSP, and UIS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

DEADLINE ALERT for EIGR, TSP, and UIS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

December 1, 2022

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

December 1, 2022

BioNTech (BNTX) Inks Research Deal With Ryvu Therapeutics

BioNTech (BNTX) Inks Research Deal With Ryvu Therapeutics

December 1, 2022

Regeneron’s (REGN) sBLA for Evkeeza Gets FDA Priority Review

Regeneron’s (REGN) sBLA for Evkeeza Gets FDA Priority Review

December 1, 2022

Eloxx Pharmaceuticals Announces Reverse Stock Split Effective

Eloxx Pharmaceuticals Announces Reverse Stock Split Effective

December 1, 2022

Cidara Therapeutics Announces Issuance of First U.S. Patent for CD388

Cidara Therapeutics Announces Issuance of First U.S. Patent for CD388

December 1, 2022

Akari Therapeutics to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech/Diagnostic Conference

Akari Therapeutics to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech/Diagnostic Conference

December 1, 2022

Citius Pharmaceuticals, Inc. Announces U.S. Food and Drug Administration Acceptance of Biologics License Application of Denileukin Diftitox for the Treatment of Patients with Persistent or Recurrent Cutaneous T-Cell Lymphoma

Citius Pharmaceuticals, Inc. Announces U.S. Food and Drug Administration Acceptance of Biologics License Application of Denileukin Diftitox for the Treatment of Patients with Persistent or Recurrent Cutaneous T-Cell Lymphoma

December 1, 2022

Syncona Limited Portfolio Company Successfully Completes Tender Offer and Acquisition of Applied Genetic Technologies Corporation

Syncona Limited Portfolio Company Successfully Completes Tender Offer and Acquisition of Applied Genetic Technologies Corporation

December 1, 2022

EIGR LAWSUIT ALERT: Levi & Korsinsky Notifies Eiger BioPharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

EIGR LAWSUIT ALERT: Levi & Korsinsky Notifies Eiger BioPharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

December 1, 2022

« 1 … 21 22 23 24 25 … 558 »